{
"id":"mk19_bb_gm_s47",
"subspecialtyId":"gm",
"title":"Female Sexual Dysfunction",
"jsonContent":{
"type":"section",
"id":"mk19_bb_gm_s47",
"title":{
"__html":"Female Sexual Dysfunction"
},
"titleNode":{
"type":"section-title",
"hlId":"f53bdb",
"children":[
"Female Sexual Dysfunction"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_gm_s47_1",
"title":{
"__html":"Diagnosis and Testing"
},
"titleNode":{
"type":"section-title",
"hlId":"d7f1cf",
"children":[
"Diagnosis and Testing"
]
},
"children":[
{
"type":"p",
"hlId":"0de0ea",
"children":[
"Female sexual dysfunction describes sexual difficulties that are persistent and distressing to the patient. Abnormalities in female sexual response fall into three categories:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"2a4c2f",
"children":[
"sexual interest/arousal disorder (lack of sexual interest and responsiveness)"
]
},
" ",
{
"type":"list-item",
"hlId":"ea477b",
"children":[
"orgasmic disorder (absence of orgasm following normal excitement phase)"
]
},
" ",
{
"type":"list-item",
"hlId":"fde34e",
"children":[
"genitopelvic pain/penetration disorder (difficulty or pain with penetration)"
]
},
" "
]
},
{
"type":"p",
"hlId":"c1bb30",
"children":[
"A pelvic examination is helpful in identifying specific areas of pain or tenderness, vulvovaginal atrophy, decreased lubrication, or tissue friability. Screening for concurrent depression is indicated because sexual dysfunction and depression often coexist."
]
},
{
"type":"p",
"hlId":"59e6ad",
"children":[
"Laboratory testing is recommended only if an underlying disorder is suspected."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_gm_s47_2",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"646e46",
"children":[
"Treat underlying contributing causes (e.g., vaginitis, interstitial cystitis, pelvic adhesions, infections, or endometriosis)."
]
},
{
"type":"p",
"hlId":"bbbde5",
"children":[
"Use lubricants as first-line therapy to alleviate dyspareunia from vaginal atrophy. Low-dose vaginal estrogen is second-line therapy for women without contraindications to estrogen. Ospemifene is a selective ",
{
"type":"abbreviation",
"title":"estrogen receptor",
"children":[
"ER"
]
},
" modulator used to treat dyspareunia associated with vulvovaginal atrophy."
]
},
{
"type":"p",
"hlId":"55707a",
"children":[
"Use ",
{
"type":"abbreviation",
"title":"cognitive behavioral therapy",
"children":[
"CBT"
]
},
" for depression or anxiety."
]
},
{
"type":"p",
"hlId":"e2a986",
"children":[
"Flibanserin may be used to treat women with low sexual desire; however, its use is limited by side effects."
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"c38290",
"children":[
"Do not treat female sexual dysfunction with low-dose testosterone or phosphodiesterase inhibitors."
]
},
" "
]
}
]
}
]
},
"tablesContent":{
}
}